<DOC>
	<DOCNO>NCT01249846</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Chlorhexidine Gluconate Chip ( PerioChip® ) frequent treatment versus routine treatment therapy adult chronic periodontitis .</brief_summary>
	<brief_title>The Efficacy Safety 2.5 mg Chlorhexidine Gluconate Chip ( PerioChip® ) Frequent Treatment Versus Routine Treatment Therapy Adult Chronic Periodontitis</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>1 . Signed date Informed Consent Form . 2 . Good general health . 3 . Male female patient age &gt; 21 year old . 4 . Availability 25 week duration study . 5 . Chronic periodontal disease natural teeth 6 . Females childbearing potential must nonpregnant nonlactating entry agree use adequate method birth control study . 1 . Oral health factor may influence outcome study . 2 . History allergy Chlorhexidine . 3 . Patient us Chlorhexidine oral rinses/mouthwashes regular basis . 4 . Patients treat medication may influence outcome study . 5 . Presence follow condition : Type 1 diabetes , uncontrolled type II diabetes , major recurrent aphtae stomatitis , abscess related oral pathology . 6 . The presence medical psychiatric condition condition , opinion Investigator , could affect successful participation patient study . 7 . Patient participate clinical study 30 day prior start study throughout study duration .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>